| Literature DB >> 34087477 |
Chiara Pozzessere1, Romain Lazor2, Raphael Jumeau3, Solange Peters4, John O Prior5, Catherine Beigelman-Aubry6.
Abstract
Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection as well as correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both HRCT and PET/CT, and stress their underlying diagnostic challenge by presenting the mimickers.Entities:
Keywords: CTLA-4 antigen; drug-related side effects and adverse reactions; immunotherapy; pneumonitis; programmed cell death 1 receptor
Year: 2021 PMID: 34087477 DOI: 10.1016/j.jtho.2021.05.017
Source DB: PubMed Journal: J Thorac Oncol ISSN: 1556-0864 Impact factor: 15.609